|
The compounds in cinnamon that affect glucose metabolism include type-A procyanidin polymers and cinnamaldehyde. A 2004 study in the Journal of Agricultural and Food Chemistry, led by USDA researchers, isolated these procyanidins and noted they activate insulin receptor kinase and enhanced insulin-dependent glucose metabolism in cell models by roughly twentyfold.
A 2013 meta-analysis in the Annals of Family Medicine pooled ten randomized controlled trials involving 543 patients with type 2 diabetes. Cinnamon at doses of 120 milligrams to 6 grams daily, taken for four to eighteen weeks, reduced fasting plasma glucose by an average of about 25 mg/dL.
The American spice aisle labeled cassia as cinnamon and sold them as interchangeable. Cassia contains roughly 250 to 1,000 times more coumarin, a compound the European Food Safety Authority flags as hepatotoxic at sustained daily doses.
Coumarin is the safety-relevant difference between the two species. The European Food Safety Authority set a tolerable daily intake of 0.1 milligrams per kilogram of body weight, which for a 70-kilogram adult means roughly 7 milligrams per day.
A single teaspoon of cassia can contain 7 to 18 milligrams of coumarin, enough to reach or exceed that limit in one serving. Ceylon cinnamon contains approximately 0.004 percent coumarin, making routine daily use far less likely to cross the safety threshold.
For anyone adding cinnamon to food each morning, the species determines whether the habit stays within safety margins or quietly exceeds them. That distinction was never part of the American conversation about cinnamon and blood sugar.
|